2,362 research outputs found
Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
There is increasing experimental evidence to suggest that expression of O6-alkylguanine-DNA-alkyltransferase (ATase) is a major factor in resistance to dacarbazine (DTIC). We recently demonstrated a progressive ATase depletion in human peripheral lymphocytes with nadir levels occurring at 4-6 h after DTIC administration (Lee et al., 1991). Therefore in an attempt to improve the clinical response rate of DTIC, fotemustine was administered 4 h after DTIC administration; since in the case of fotemustine, ATase removes the chloroethyl lesions from the O6-position of guanine, thereby preventing the formation of the cytotoxic cross-links. Sixty patients with widely metastatic melanoma received DTIC at 400, 500 or 800 mg m-2 followed by fotemustine (100 mg m-1) at 4 h after DTIC administration. Treatment was repeated every 28 days with a total of 169 cycles of chemotherapy administered; 75, 57 and 37 treatment cycles with 400, 500 and 800 mg m-2 DTIC groups respectively. Eighteen of the 60 patients responded (with three complete response); response rates were linearly related to dose, being 24%, 30% and 40% in patients receiving 400, 500 and 800 mg m-2 of DTIC respectively and the overall response rate was 30%. Median survival was 3.6 months (range, 1-15 months) with no statistically significant difference between the different DTIC treatment groups (P = 0.67). Nine patients are alive at 5 to 26 months (median 10 months); three patients with no tumour and five patients with stable disease. A statistically significant relationship was seen between the development of severe haematological toxicity (WHO > or = 3) with increasing dosage of DTIC and significant subclinical pulmonary damage was seen in 11 patients where the lung function was monitored during the course of treatment. In conclusion, it appears that with this small group of patients, escalation of DTIC dosage might not significantly affect response rates but does increase haematological toxicity. The present study provides a framework for other studies in an attempt to modulate ATase-mediated drug resistance in tumour tissues but the associated toxicity will need careful monitoring
Recommended from our members
Videographic and GPS techniques for monitoring active glacial surge: Bering Glacier, Alaska
Aerial videography in combination with GPS were used to monitor the
active surge of Alaska's Bering Glacier. The large aerial extent of the study area and the
unpredictable weather in coastal Alaska required innovative techniques to be used in
order to successfully monitor the surge environment. A portable aerial videographic
system which mounts in a variety of small aircraft was developed to allow detailed
mapping of the glacier's terminus under a variety of conditions. This system is
georeferenced with GPS tracking of the aircraft, as well as GPS ground truthing and
rectification of imagery and mapping products. This allowed precise mapping in a region
with no established survey network. Video imagery is encoded with GPS time to allow
precise location of individual frames of video imagery allowing mapping accuracies of
approximately 20 meters. Long distance differential correction of the GPS data improved
the accuracies to close to 10 meters. Additional work with time-lapse videography
allowed detailed analysis of small sections of the terminus to be studied over longer time
periods
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
One hundred and fifty-nine previously untreated patients with small cell lung cancer (SCLC), who were not eligible for intensive chemotherapy, were entered into a randomised study of intravenous (i.v.) doxorubicin and ifosfamide (with mesna) and oral etoposide. The i.v. drugs were given either by bolus therapy or by a continuous infusion (CI) pump over 7 days via a central venous line. Therapy was given for 6 weeks only. On weeks 1, 3 and 5 IV doxorubicin 35 mg m-2 was given with 5 days of oral etoposide 100 mg m-2 daily. On weeks 2, 4 and 6 IV ifosfamide 5 g m-2 was given with equidose mesna. The overall median survival was 25 weeks for patients in the bolus arm and 30 weeks for the CI therapy (P = 0.45). The overall response rate was 64% (18% complete response-CR) and 69% (30% CR) respectively (P = 0.13). The median WHO score for haematological toxicity was 4 for bolus therapy and 3 for CI therapy (P = 0.0007). Despite a trend for less supportive care for patients on CI therapy there were no significant differences in the use of i.v. antibodies and blood or platelet transfusions. There were fewer treatment delays due to myelotoxicity in the CI arm (P = 0.04). The median WHO score for non-haematological toxicity was 2 in both treatment groups. There was significantly less nausea (P = 0.037) but more mucositis (P = 0.01) in the CI arm. Weekly chemotherapy using CI treatment was as effective as bolus therapy. It was well accepted by patients. The assessment of quality of life in a subgroup of patients showed a statistically significant reduction in anxiety and depression for both groups of patients during therapy
Logics for Unranked Trees: An Overview
Labeled unranked trees are used as a model of XML documents, and logical
languages for them have been studied actively over the past several years. Such
logics have different purposes: some are better suited for extracting data,
some for expressing navigational properties, and some make it easy to relate
complex properties of trees to the existence of tree automata for those
properties. Furthermore, logics differ significantly in their model-checking
properties, their automata models, and their behavior on ordered and unordered
trees. In this paper we present a survey of logics for unranked trees
- …